Loading Events

« All Events

  • This event has passed.

Cannabis Society Executive Business Conference Berlin

February 13

Cannabis Society Executive Business Conference Berlin

The Cannabis Society Executive Business Conference – We are dedicated to fostering the cannabis community through events, conferences, dinners, & many more. Join us for a unique deal-making session and to hear from industry experts, entrepreneurs, investors and service providers on what is to come in this emerging industry. Berlin, Germany; Feb 13, 2020

The Cannabis Society is proud to present our Executive Business Conference on February 13th in Berlin.


9:30 – Registration
10:30 – Opening Remarks
10:45 – Keynotes & Panel Discussions
12:30 – BREAK
13:30 – Keynotes & Panel Discussions
15:00 – Closing Remarks followed by Networking


Jens Kramer, VP Europe operations, Avicanna Inc.

Linus Weber, Founder & CEO at Nimbus Health GmbH

Linus Maximilian Weber is an experienced Business Consultant, Founder and Chief Executive in the health care industry. Linus has been working at Ernst & Young in the Compliance and Quality Management Consulting unit prior to joining Fresenius Medical Care the world’s leading company in renal care. He is a certified Project Management Consultant and GDP Responsible for the pharmaceutical distribution business. In 2018 after building the Compliance Management System at Fresenius he founded Nimbus Health a fully licensed pharmaceutical wholesaler in Germany, where he serves as Chief Executive Officer. The focus of Nimbus Health is to improve the wellbeing of patients by giving consistent and standardized access to alternative therapies based on Medicinal Cannabis and to reshape the health care system by developing additional Cannabis products.

Chana Greenberger | VP Of Business Development of Brains Bioceutical

• Business Development Lead for the Centre for Medicinal Cannabis
• Head of Business Development for Hadasit Medical Research Services and Development
• Previous experience in investment management

Peter Homberg, Partner, Dentons

Peter Homberg is a partner in the Dentons Berlin office. He focuses on life sciences, IP, corporate law and M&A transactions in the life sciences and high-tech sector as well as in R&D and cooperation agreements, cross-border IP licensing and IP strategies. Furthermore, he has extensive experience providing legal advice on compliance issues. Additionally, he is the head of the European Cannabis sector group. Peter advises inter alia companies in the pharmaceutical, diagnostics, biotechnology, medical device, and medical cannabis industries—from startups to large publicly listed companies. Furthermore, he has broad transactional experience in Southeast Asia. Peter is a member of the Licensing Executive Society (LES), the German Association for Intellectual Property and Copyright (GRUR), the German Institution for Arbitration (DIS) as well as the Pharma-Lizenz-Club Deutschland e.V. He regularly holds lectures at seminars and conferences. He is the author of numerous professional articles and other publications regarding corporate or IP law in the field of life sciences.

Boris Blatnik, Chief Strategy Officer, KannaSwiss

Boris serves as CEO of KannaSwiss. He joined the team in January of 2017 and has been instrumental in the rebranding and business development of the company. Prior to KannaSwiss Boris served as CSO and Co-founder of Numbridge Inc. from 2009 until 2016. Numbridge was a telecommunication app that helped people communicate over the GSM network. Boris served as CEO & Co-founder of Atlas Commercial Holdings from 2004 until 2009. Atlas established an interlocking network of global business alliances and partnerships to provide customized solutions that enable governments and local businesses in emerging markets to stabilize and upgrade their basic infrastructures. Formerly he was Founder & President of V Karting, an integrated go-kart facility with conference rooms, restaurant, and entertainment/game space. His experiences range from construction to telecommunications to natural resource consulting working with such companies as MAN Ferrostaal and Petrobras.

Boris earned his A-levels from Aiglon College in Villars, Switzerland and then attended American University in Washington, DC. Born in Caracas, Venezuela, Boris was raised in Switzerland and moved to the U.S. to attend university. He is fluent in English, Spanish, French, German, Italian, and Portuguese.

Simon Tankel, President, Wundr Co.

Simon is the President of Wundr. His previous cannabis experience includes founding Golders Hill (merged into Wundr), Ark Wellness and investment practice for a family office. Previously, he was Head of Business Development at Sum International, focusing on power plant development and latterly cannabis investing.

Dr. Constantin von der Groeben, Managing Director, DEMECAN

Dr. Constantin von der Groeben is a co-founder and managing director of DEMECAN, and leads the company’s legal and regulatory affairs department. Under his direction, DEMECAN’s Joint Venture with Canadian LP Wayland won Germany’s tender process on cannabis cultivation licenses. Dr. vonder Groeben’s expertise lies in the regulatory framework of medicinal cannabis including EU-GMP, narcotics, and pharmaceutical law. He believes that smart regulation of medicinal cannabis will allow for the development of a genuine pharmaceutical product that will be widely accepted by doctors, patients, and society as a whole.

Boris Moshkovits, Co-founder and Managing Director, alephSana

Boris Moshkovits is a Cannapreneur and experienced founder with a demonstrated history of working in the media, pharma and internet industry. He is the co-founder and managing director of alephSana, a company focused on scouting for qualified medical cannabis products globally and on bringing the best cannabis therapeutics to Germany and Europe. Moshkovits has served as an International digital marketing manager in the pharma industry walking the fine line of marketing and digital storytelling in highly regulated markets. As a speaker Moshkovits has been talking about the mainstreaming of medical cannabis and the future of cannabis as a lifestyle product. He is also the co-founder of the CannaBusinessClub.Berlin, an initiative to empower the local cannabis scene. In his publishing career, he was the head of digital media for Ringier Publishing Germany and publisher of Amuse for Vice Media Germany. Prior to this, he has worked as an editor and publisher in Milan, Moscow and New York.

Juriën Koster, Vice-President International Relations at Ofinext and Director at C.I.E.

Active in the cannabis industry since 2017. Help to build four different companies from the ground up. Actively developing a professional cannabis industry in The Netherlands and Europe. Occasional speaker at cannabis conventions and advisor to trade shows and events. Expertise in the technical and pharmaceutical aspects of the market.

An international spokesperson for Ofinext. Building and maintaining a broad network of different stakeholders with a focus on the pharmaceutical aspect of the market. Developing our own Ofinext pharmaceutical products (EU-GMP certified full-spectrum API’s) and looking for new possibilities.

Lead role in the Ofinext clinical trials. In charge of project management and making strategic decisions regarding the trials.

Actively lobbying for the cannabis industry in Europe and most notably The Netherlands, by organizing cannabis events and the development of a scientific cannabis center in Wageningen.

Benjamin Patock, Head of International Relations, Boveda

Benjamin cares for one thing: To secure high-quality standards for cannabis products around the globe. As Head of International Relations for Boveda (http://www.bovedainc.com), the global leader in 2-way humidity control, he is at the center of this movement, as water activity is one of the most dominant factors for product quality and safety. Boveda, celebrating over 20 years in business, produces a very natural, reliable, stable, safe and at the same time inexpensive and disposable device that controls humidity levels by adding and removing water content within any type of closed container.

Prior to his engagement at Boveda, Benjamin’s career included a turn as a product and marketing specialist. Prior to his studies, he designed his first online projects in 1999 which lead him to different roles for big agencies and corporations alike. In 2006 he took a leap of faith and joined a friend in his freshly founded start-up and stayed in this ecosystem founding two companies of his own. The most recent one, Noblego (http://www.noblego.de), is today one of the leading European retailers of cigars and premium tobacco products. Benjamin lectured at University level, wrote one of the best-selling cigar books in German language (http://amzn.to/2BP70H2) and acts as speaker and activist for consumer rights groups. He now takes his experiences from a highly regulated tobacco market to bring high-quality cannabis medicine to anyone who needs it, no matter location.

Finn Age Hänsel, Founder & Managing Director, Sanity Group

Finn Age Hänsel, 36, studied Business Administration in Germany, Hungary, and New Zealand. Following a 4-year engagement at BCG with a focus on medical and health, he joined Rocket Internet in Australia from 2011 to 2013, as a Managing Director. After founding the largest Australian online fashion retailer, THE ICONIC, he went on to become the Managing Director of the ProSiebenSat1-Incubator, EPIC Companies. In 2015 he founded the Berliner Berg brewery and became a Business Angel for multiple Berlin start-ups including CrossEngage, SMACC, Cars24, and Einhorn. After 4 years of being CEO at the scale-up Movinga, Finn founded the Sanity Group, a European Cannabis company, together with Fabian Friede.

Cannabis Society Executive Business Conference Berlin

European Cannabis Calendar

Call Now